by Eric Christianson | Nov 20, 2024 | Renal, Urology, and Electrolytes Case Studies
A 75-year-old female has a history of mild cognitive impairment, GERD, hypertension, osteoarthritis, and overactive bladder. Recognizing the relationship of oxybutynin and cognitive impairment is incredibly important in geriatrics and in the case scenario, we outline...
by Eric Christianson | Sep 22, 2021 | Medication and Disease State Clinical Pearls For Pharmacists
Vibegron (Gemtesa) is a selective beta-3 adrenergic receptor agonist. It treats OAB, including urge urinary incontinence and urinary frequency by relaxing the detrusor smooth muscle during bladder filling. Thus, increasing bladder capacity. Vibegron is dosed once...
by Eric Christianson | May 6, 2020 | Medication and Disease State Clinical Pearls For Pharmacists, Renal, Urology, and Electrolytes Medication and Disease State Clinical Pearls
Mirabegron is a medication that can be used for overactive bladder. It is a medication that I am seeing used periodically in clinical practice. Here are a few mirabegron clinical pearls that I think are valuable to remember. The mechanism of action is critical to...
by Eric Christianson | Oct 30, 2019 | Drug Interaction Case Studies and Education For Pharmacists
In this case scenario below, I discuss the mirabegron tamoxifen interaction and how it can impact patient safety. KS is a 61-year-old female who presents with worsening urinary frequency. She has been diagnosed with overactive bladder and place on oxybutynin. She was...
